ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 56 filers reported holding ARYA SCIENCES ACQU CORP IV in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,940,000 | -1.2% | 300,000 | 0.0% | 0.38% | +27.2% |
Q4 2021 | $2,975,000 | -1.3% | 300,000 | 0.0% | 0.30% | -36.6% |
Q3 2021 | $3,015,000 | -6.2% | 300,000 | 0.0% | 0.47% | -5.1% |
Q2 2021 | $3,216,000 | +2.4% | 300,000 | 0.0% | 0.50% | -12.5% |
Q1 2021 | $3,142,000 | – | 300,000 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |